Melanoma Peptide MHC Specific TCR Expressing T-Cell Membrane Camouflaged PLGA Nanoparticles for Treatment of Melanoma Skin Cancer von Yaman, Serkan, Ramachandramoorthy, Harish, Oter, Gizem, Zhukova, Daria, Tam Nguyen, Sabnani, Manoj K., Weidanz, Jon A., Nguyen, Kytai T.

Volltext

Targeted chemotherapy via HER2-based chimeric antigen receptor (CAR) engineered T-cell membrane coated polymeric nanoparticles von Yaman, Serkan, Ramachandramoorthy, Harish, Iyer, Priyanka, Chintapula, Uday, Nguyen, Tam, Sabnani, Manoj, Kotadia, Tanviben, Ghaffari, Soroush, Pop, Laurentiu M., Hannan, Raquibul, Weidanz, Jon A., Nguyen, Kytai T.

Volltext

Antitumor Activity of a Monoclonal Antibody Targeting Major Histocompatibility Complex Class I-Her2 Peptide Complexes von JAIN, Rinki, RAWAT, Amit, VERMA, Bhavna, MARKIEWSKI, Maciej M, WEIDANZ, Jon A

Volltext

Identification of Breast Cancer Peptide Epitopes Presented by HLA-A0201 von Hawkins, Oriana E, VanGundy, Rodney S, Eckerd, Annette M, Bardet, Wilfried, Buchli, Rico, Weidanz, Jon A, Hildebrand, William H

Volltext

Antibody Targeting to a Class I MHC-Peptide Epitope Promotes Tumor Cell Death von Wittman, Vaughan P, Woodburn, David, Nguyen, Tiffany, Neethling, Francisca A, Wright, Stephen, Weidanz, Jon A

Volltext

Levels of Specific Peptide-HLA Class I Complex Predicts Tumor Cell Susceptibility to CTL Killing von Weidanz, Jon A, Nguyen, Tiffany, Woodburn, Tito, Neethling, Francisca A, Chiriva-Internati, Maurizio, Hildebrand, William H, Lustgarten, Joseph

Volltext

TCR Mimic Monoclonal Antibody Targets a Specific Peptide/HLA Class I Complex and Significantly Impedes Tumor Growth In Vivo Using Breast Cancer Models von Verma, Bhavna, Neethling, Francisca A, Caseltine, Shannon, Fabrizio, Ginger, Largo, Sherly, Duty, J. Andrew, Tabaczewski, Piotr, Weidanz, Jon A

Volltext

Immunodominant West Nile Virus T Cell Epitopes Are Fewer in Number and Fashionably Late von Kaabinejadian, Saghar, McMurtrey, Curtis P, Kim, Sojung, Jain, Rinki, Bardet, Wilfried, Schafer, Fredda B, Davenport, Jason L, Martin, Aaron D, Diamond, Michael S, Weidanz, Jon A, Hansen, Ted H, Hildebrand, William H

Volltext

TCR-like antibody drug conjugates mediate killing of tumor cells with low peptide/HLA targets von Lowe, Devin B., Bivens, Camille K., Mobley, Alexis S., Herrera, Christian E., McCormick, Amanda L., Wichner, Timea, Sabnani, Manoj K., Wood, Laurence M., Weidanz, Jon A.

Volltext

TCR mimic monoclonal antibodies induce apoptosis of tumor cells via immune effector-independent mechanisms von Verma, Bhavna, Jain, Rinki, Caseltine, Shannon, Rennels, Aaron, Bhattacharya, Raktima, Markiewski, Maciej M, Rawat, Amit, Neethling, Francisca, Bickel, Ulrich, Weidanz, Jon A

Volltext

OR8 Quantitative assessment of HLA class I presentation in ICT-107, a dendritic cell-based immunotherapy von Kaabinejadian, Saghar, Buchli, Rico, Swanson, Steven J, Gringeri, Anthony J, Weidanz, Jon A, Hildebrand, William H

Volltext

Human Leukocyte Antigen-Presented Macrophage Migration Inhibitory Factor Is a Surface Biomarker and Potential Therapeutic Target for Ovarian Cancer von Patterson, Andrea M, Kaabinejadian, Saghar, McMurtrey, Curtis P, Bardet, Wilfried, Jackson, Ken W, Zuna, Rosemary E, Husain, Sanam, Adams, Gregory P, MacDonald, Glen, Dillon, Rachelle L, Ames, Harold, Buchli, Rico, Hawkins, Oriana E, Weidanz, Jon A, Hildebrand, William H

Volltext

Single-Chain HLA-A2 MHC Trimers That Incorporate an Immundominant Peptide Elicit Protective T Cell Immunity against Lethal West Nile Virus Infection von Kim, Sojung, Li, Lijin, McMurtrey, Curtis P, Hildebrand, William H, Weidanz, Jon A, Gillanders, William E, Diamond, Michael S, Hansen, Ted H

Volltext

A novel T‐cell receptor mimic defines dendritic cells that present an immunodominant West Nile virus epitope in mice von Kim, Sojung, Pinto, Amelia K., Myers, Nancy B., Hawkins, Oriana, Doll, Krysten, Kaabinejadian, Saghar, Netland, Jason, Bevan, Michael J., Weidanz, Jon A., Hildebrand, William H., Diamond, Michael S., Hansen, Ted H.

Volltext

Detection of human leukocyte antigen biomarkers in breast cancer utilizing label-free biosensor technology von Weidanz, Jon A, Doll, Krysten L, Mohana-Sundaram, Soumya, Wichner, Timea, Lowe, Devin B, Gimlin, Susanne, Wawro Weidanz, Debra, Magnusson, Robert, Hawkins, Oriana E

Volltext

Assessing vaccine potency using TCRmimic antibodies von Neethling, Francisca A, Ramakrishna, Venky, Keler, Tibor, Buchli, Rico, Woodburn, Tito, Weidanz, Jon A

Volltext

One-step fabrication of flexible nanotextured PDMS as a substrate for selective cell capture von Hasan, Mohammad R, Peri, Sai Santosh Sasank, Sabane, Viraj P, Mansur, Nuzhat, Gao, Jean X, Nguyen, Kytai T, Weidanz, Jon A, Iqbal, Samir M, Abhyankar, Vinay V

Volltext

Direct discovery and validation of a peptide/MHC epitope expressed in primary human breast cancer cells using a TCRm monoclonal antibody with profound antitumor properties von Verma, Bhavna, Hawkins, Oriana E, Neethling, Francisca A, Caseltine, Shannon L, Largo, Sherly R, Hildebrand, William H, Weidanz, Jon A

Volltext

A novel vascular targeting strategy for brain-derived endothelial cells using a TCR mimic antibody von Bhattacharya, Raktima, Xu, Yan, Rahman, Md. Ashequr, Couraud, Pierre-Olivier, Romero, Ignacio A., Weksler, Babette B., Weidanz, Jon A., Bickel, Ulrich

Volltext

Sperm protein 17 is a suitable target for adoptive T-cell-based immunotherapy in human ovarian cancer von Chiriva-Internati, Maurizio, Weidanz, Jon A, Yu, Yuefei, Frezza, Eldo E, Jenkins, Marjorie R, Kennedy, Ronald C, Cobos, Everardo, Kast, W Martin

Volltext